GR3005677T3 - - Google Patents

Info

Publication number
GR3005677T3
GR3005677T3 GR920402003T GR920402003T GR3005677T3 GR 3005677 T3 GR3005677 T3 GR 3005677T3 GR 920402003 T GR920402003 T GR 920402003T GR 920402003 T GR920402003 T GR 920402003T GR 3005677 T3 GR3005677 T3 GR 3005677T3
Authority
GR
Greece
Application number
GR920402003T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005677T3 publication Critical patent/GR3005677T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR920402003T 1987-01-28 1992-09-10 GR3005677T3 (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1882087 1987-01-28
JP6535287 1987-03-18

Publications (1)

Publication Number Publication Date
GR3005677T3 true GR3005677T3 (en:Method) 1993-06-07

Family

ID=26355556

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402003T GR3005677T3 (en:Method) 1987-01-28 1992-09-10

Country Status (6)

Country Link
EP (1) EP0284180B1 (en:Method)
KR (1) KR930006192B1 (en:Method)
CA (1) CA1323364C (en:Method)
DE (1) DE3873797T2 (en:Method)
ES (1) ES2043798T3 (en:Method)
GR (1) GR3005677T3 (en:Method)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1324129C (en) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
ATE82499T1 (de) * 1987-09-18 1992-12-15 R Tech Ueno Ltd Okulare hypotensivagenzien.
US5236907A (en) * 1988-10-01 1993-08-17 R-Tech Ueno Ltd. Ocular hypotensive agents
US6420422B1 (en) 1987-09-18 2002-07-16 Sucampo Pharmaceuticals, Inc. Ocular hypotensive agents
JP2597629B2 (ja) 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 13,14−ジヒドロ−15−ケトプロスタグランジン類の安定化
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
DE69019431T2 (de) * 1989-07-27 1995-09-14 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von 15-Keto-Prostansäure-Derivaten zur Herstellung eines Medikaments für die Verbesserung der Ausscheidung des Kaliumions.
CA2022372C (en) * 1989-08-09 2000-05-02 Ryuji Ueno Improvement of excretion of nonprotein nitrogen into the intestine by prostanoic acid derivatives
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
TW224942B (en:Method) * 1990-04-04 1994-06-11 Adka Ueno Kk
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ES2093774T3 (es) * 1991-03-14 1997-01-01 R Tech Ueno Ltd Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
CA2150287C (en) * 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
CA2279267C (en) * 1997-11-28 2010-01-12 R-Tech Ueno, Ltd. Use of 15-ketoprostaglandin e compounds as endothelin antagonist
US6506799B1 (en) 1999-04-01 2003-01-14 Esperion Therapeutics, Inc. Methods of treating cardiovascular diseases, dyslipidemia, dyslipoproteinemia, and hypertension with ether compounds
TWI263505B (en) 2001-11-19 2006-10-11 Sucampo Ag Pharmaceutical composition comprising a C1C-2 channel opener
US20060281818A1 (en) * 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836578A (en) * 1965-12-16 1974-09-17 Kemiska Inst Prostanoic acid derivatives
GB1476661A (en) * 1974-05-13 1977-06-16 American Cyanamid Co Prostaglandins

Also Published As

Publication number Publication date
DE3873797T2 (de) 1993-01-21
KR930006192B1 (ko) 1993-07-08
ES2043798T3 (es) 1994-01-01
DE3873797D1 (de) 1992-09-24
EP0284180B1 (en) 1992-08-19
EP0284180A1 (en) 1988-09-28
CA1323364C (en) 1993-10-19
KR880008985A (ko) 1988-09-13

Similar Documents

Publication Publication Date Title
IN170553B (en:Method)
DE3868177D1 (en:Method)
IN170183B (en:Method)
DE3866718D1 (en:Method)
GR3003732T3 (en:Method)
IN169456B (en:Method)
DE3866159D1 (en:Method)
IN171484B (en:Method)
IN170529B (en:Method)
CH678786GA3 (en:Method)
CH680485GA3 (en:Method)
IN170711B (en:Method)
AU5597786A (en:Method)
AU6245986A (en:Method)
AU6250086A (en:Method)
AU5724886A (en:Method)
IN170448B (en:Method)
IN168300B (en:Method)
AU6301290A (en:Method)
AU6687386A (en:Method)
IN169228B (en:Method)
IN166977B (en:Method)
AU6085986A (en:Method)
AU7621687A (en:Method)
BG44634A1 (en:Method)